Press releases

October 27, 2016

Verlyx Pharma announces new data on VLX103 to be presented at the AASLD 2016 Annual Liver Meeting

August 23, 2016

Verlyx Pharma receives U.S. patent for its lead product VLX103 for the treatment of liver diseases or conditions